InvestorsHub Logo
Followers 400
Posts 17747
Boards Moderated 0
Alias Born 07/14/2003

Re: INTEGRITY STOCKS post# 74013

Tuesday, 03/06/2018 1:16:48 PM

Tuesday, March 06, 2018 1:16:48 PM

Post# of 195018
RXMD- Very Nice Article Dart Trader Stocks:

March 6th 2018 - Progressive Care (RXMD) One Of The Best Stock Investments For 2018

It is very rare to find a stock like Progressive Care (RXMD) trading at such a low level! Progressive Care (RXMD) is THE #1 stock to buy right now, one of the most undervalued stocks in America!

Currently trading at a deep discount under 20 cents per share, analysts believe the current fair value of the company right now should be close to a dollar plus per share, reaching multi dollars per share as it's revenues continue increasing as it expands across the nation.
Progressive Care (RXMD) has gone from generating $9 million in revenues in 2013 to $20 million in 2017, trouncing CVS, Walgreens and Rite-Aid average per store pharmacy revenues.
Progressive Care (RXMD) employs a highly successful business model of being a Healthcare Services and Technology company that provides excellent and affordable services while lowering the cost. With expansion plans across Florida and now licensed in 10 States Progressive Care (RXMD) is building a national brand!
These expansions plans are well underway, on March 2nd 2018, Progressive Care (RXMD) announced they intent to purchase another pharmacy in Palm Beach County, CEO Shital Mars stated that they have rapidly been gaining ground in Palm Beach County and this was "just the beginning of an aggressive expansion agenda that allows the Company to reach thousands of new doctors and patients" with it's outstanding and lucrative business model.
As they expand, this will easily become a $100 million plus revenue company! Progressive Care (RXMD) will continue to gain efficiencies that will enhance the bottom line, and the share price is only going to keep rising! Along with the $20 million net revenue attained in 2017, Progressive Care (RXMD) is set to achieve the gold standard for allowing institutional funds to pour into the stock as they prepare to soon release their second consecutive year of audited financials.


In fact it now appears that thus has already begun as fund managers start to pour new money into Progressive Care (RXMD). Make no mistake about it, more and more institutional investing is coming to Progressive Care (RXMD). If ever there was a time to buy shares, it is now, institutional investing is just one of the catalysts that will continue to propel Progressive Care (RXMD) share price much higher!
Online retailer Amazon, Berkshire Hathaway and JPMorgan Chase & Co. just announced that they will form an “independent company” to improve healthcare and lower costs for their hundreds of thousands of U.S. employees.
Progressive Care's (RXMD) incredibly successful pharmaceutical business model which delivers improved healthcare at lower costs is exactly what Amazon, Berkshire Hathaway and JPMorgan Chase & Co are striving for. Amazon's entry into the healthcare space has been rumored for months, with many observers speculating the e-commerce giant might expand into retail pharmacy and battle the likes of CVS Health and Walgreens Boots Alliance.
South Florida where Progressive Care (RXMD) is based, is a hotspot for the nationwide trend of small pharmaceutical/healthcare acquisitions in this sector. This gives even more added value to Progressive Care (RXMD) who are already two steps ahead of these big players now entering the pharmaceutical/healthcare market.

Progressive Care (RXMD) is well established and positioned to rival AMAZON to become potentially one of the largest online pharmacy and healthcare services companies!

Progressive Care (RXMD) has already confirmed they are actively looking at various merger and acquisition opportunities, so it will not come as a surprise to see a major player scoop up Progressive Care (RXMD), a cash flow positive, profitable and successful company.

As mentioned earlier, Progressive Care (RXMD) is blowing away the competition, their revenue is far superior when you compare the revenue per store of the current big 3 players.
Numbers don't lie, they are screaming that Progressive Care (RXMD) is a STRONG BUY NOW! Just look at how strong Progressive Care (RXMD) is, in fact even if you added all three of these nationwide chains per store average together Progressive Care (RXMD) easily beats them all combined! Take a look:

-CVS Pharmacy Revenues average of $8.5 million per store.
-Walgreens Pharmacy Revenues average of $6.6 million per store.
-Rite Aid's Pharmacy Revenues average of $4.2 million per store.
-Progressive Care (RXMD) revenues were $20.1M in 2017 and are forecast to bring in around $22-25 million this year EVEN without any expansion or merger or acquisition!

Progressive Care (RXMD) has one of the State of Florida's leading pharmaceutical compounders on it's staff allowing it to prepare medications tailored to meet individual patients needs.
Progressive Care (RXMD) is also in the forefront of researching the development and application of compounding Pharmaceutical and over the counter drugs based on Cannabis. Progressive Care (RXMD) have a dedicated R&D department working on these products in house. Researchers have used their understanding of how the brain processes cannabinoids to develop drugs which follow the same pathways but work differently than marijuana. CBD, or cannabidiol, is a compound in marijuana that offers many benefits without any high.


On February 27th 2018, in an investor communication Progressive Care (RXMD) reported positive results on their CBD/Hemp Compound R&D product and stated they are now in talks with CBD manufacturers for future production needs.

The company is very excited about this new revenue stream with good reason.
There is a huge ever growing market for their product. Forbes reported that the CBD market will grow to a $2.1 billion market in consumer sales by 2020. With this market growing in leaps and bounds Progressive Care (RXMD) revenues are forecast to skyrocket!
The added value here is that this product does not have to be in a prescription drug format, It can be sold in over the counter compound formula's allowing easier access to this type of product while generating huge new revenue streams for Progressive Care (RXMD).

CBD appears to be helpful for many health conditions, including epilepsy, anxiety, chronic pain, and more. Doctors are generally supportive of CBD because it has very few side effects.

In a recent interview CEO Shital Mars stated "we are at the beginning, we are at the cusp of something great."
Before I invest in any stock I'm looking for 3 things in the CEO, intelligence, energy and integrity. If they don't have the last one, don't even bother with the first two.
CEO Shitak Mars is outstanding and has all 3 qualities that allow me to sleep soundly at night knowing that my investment is very safe!

Clearly Progressive Care (RXMD) business model is setting the standard for the pharmaceutical and healthcare sector, once again CVS,Walgreens and Rite Aid don't even come close!


Progressive Care (RXMD) ALSO just reported they had broken another record, they announced a record breaking month for January 2018!
\Progressive Care (RXMD) filled over 23,000 prescriptions during the month of January, generating $1.8 million in net revenues. Prescriptions filled increased by 34% compared to the same month last year and by 10% over the last record breaking month in October 2017. Revenues increased by approximately 9% as compared to January 2017. The company also filled over $450,000 worth of prescriptions (not included in Net Revenues) for 340B entities in January, generating fees to the pharmacy of just over $20,000. Progressive Care (RXMD) is growing faster and faster every year, the CEO Shital Mars has stated they are successfully executing their game plan with the goal of to uplisting to the NASDAQ, it now appears that moving to the NASDAQ is not a matter of IF but WHEN. With the share price currently under 20 cents a share RXMD is without doubt one of the most undervalued stocks in America!

On February 15th 2018 Progressive Care (RXMD) announced that its retail pharmacy will officially begin accepting Bitcoin payments. Customers that choose to pay using Bitcoin will undergo a similar payment process as customers using credit cards or online payment processing platforms such as Paypal. Progressive Care (RXMD) continues evolving both operationally and technologically making it one of the few pharmacies in the country enabling systems for cryptocurrency acceptance.

Progressive Care (RXMD) will use external payment providers, such as BitPay, to process all Bitcoin payments. BitPay compliance analysts approved the pharmacy for Tier 2 volume processing limit on February 14, 2018. Tier 2 provides daily cash settlements in USD and has a $500,000 annual limit. This will allow the pharmacy to reach more customers who are increasingly using cryptocurrencies for daily purchases.

More Progressive Care (RXMD) HIGHLIGHTS

Progressive Care (RXMD) through its 100% owned subsidiaries PharmCo and Smart Medical Alliance has quickly become one one of South Florida's leading Health Services organisations.

Progressive Care (RXMD) is so successful and here is why. They have created the next generation of pharmacy care. Rite-Aid, Walgreens and CVS don't even come close!





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News